GB971239A - Therapeutic composition having hypotensive and vasodilator activity - Google Patents

Therapeutic composition having hypotensive and vasodilator activity

Info

Publication number
GB971239A
GB971239A GB4581062A GB4581062A GB971239A GB 971239 A GB971239 A GB 971239A GB 4581062 A GB4581062 A GB 4581062A GB 4581062 A GB4581062 A GB 4581062A GB 971239 A GB971239 A GB 971239A
Authority
GB
United Kingdom
Prior art keywords
hypotensive
therapeutic composition
vasodilator activity
vasodilator
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4581062A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biofarma SA
Original Assignee
Biofarma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR881057A external-priority patent/FR32F/en
Application filed by Biofarma SA filed Critical Biofarma SA
Publication of GB971239A publication Critical patent/GB971239A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions comprise in combination 2,3,4 - trimethoxy - benzylpiperazine dihydrochloride, the reserpate of formula <FORM:0971239/A5-A6/1> (i.e. rescinnamine) and a pharmaceutical excipient. Tablets are described. The compounds act synergistically against hypertension.
GB4581062A 1961-12-05 1962-12-04 Therapeutic composition having hypotensive and vasodilator activity Expired GB971239A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR881057A FR32F (en) 1960-06-30 1961-12-05 New vasodilator substance.

Publications (1)

Publication Number Publication Date
GB971239A true GB971239A (en) 1964-09-30

Family

ID=8768124

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4581062A Expired GB971239A (en) 1961-12-05 1962-12-04 Therapeutic composition having hypotensive and vasodilator activity

Country Status (1)

Country Link
GB (1) GB971239A (en)

Similar Documents

Publication Publication Date Title
SE8700499D0 (en) NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
MY101784A (en) Novel pharmacological compounds
ES425514A1 (en) Coumarin derivatives for the treatment of allergies
GB971239A (en) Therapeutic composition having hypotensive and vasodilator activity
BE622943A (en) Therapeutic compositions, containing emetine derivatives.
ES269442A1 (en) Lysine orotate
GB1013910A (en) New derivative of gitoxin, the use and preparation thereof
ES294897A1 (en) Improvements introduced in the preparation of pharmaceutical compositions in the form of unit dose (Machine-translation by Google Translate, not legally binding)
GB1090481A (en) Improvements in and relating to diuretic compositions
IL37116A0 (en) Pharmaceutical compositions containing derivatives of l-(3,4-dihydroxy-phenyl)alanine
PH12135A (en) Anthelmintic pharmaceutical preparations containing 4-(4-nitroanilino)-phenylisothiocyanate
GB1000783A (en) Improvements in or relating to pharmaceutical compositions containing polyhydroxybenzene derivatives
ES283585A1 (en) A procedure for the preparation of a therapeutic composition (Machine-translation by Google Translate, not legally binding)
BE789189A (en) IMPROVEMENTS IN THE PROCESSES FOR PREPARATION, DEPYROGENATION AND STABILIZATION OF UROKINASE AND COMPOSITIONS OBTAINED
GB998051A (en) Pharmaceutical compositions comprising n-(5-nitro-2-furfurylidene)-1-aminohydentoin, tetracycline and 2-amino-d-glucose
ES331866A1 (en) A procedure to compose therapeutic compositions. (Machine-translation by Google Translate, not legally binding)
FI752920A (en)
GB942981A (en) Therapeutic composition having a hypotensive action and containing a mixture of 3-hydrazino 6-carbamoyl pyridazine and reserpine
GB1088466A (en) Medicaments comprising 5-nitrouracil
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
GB918066A (en) 1,2-diphenyl-4-carbamoyl-3,5-pyrazolidinedione and salts
HU174754B (en) Process for producing 1,3-dihydro-spiro-bracket-isobenzo-furane-1,4-piperidine-bracket closed derivatives and pharmaceutical compositions containing them as active agents
GB1047919A (en) Morpholine derivative, preparation thereof and compositions containing same
GB1091134A (en) Pharmaceutical and veterinary compositions comprising a sorbitol acetal
GB2012166A (en) Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts.